The long isoform of FABP6 facilitates WWP2‐mediated PTEN ubiquitination to activate AKT/mTOR signalling and contributes to reduced everolimus sensitivity in clear cell renal cell carcinoma
Clinical and Translational Medicine · 2026
DOI: 10.1002/ctm2.70880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2026. Verfasst von Haoming Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Everolimus, Carcinoma, Renal Cell, TOR Serine-Threonine Kinases. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
How PTEN function is impaired in clear cell renal cell carcinoma (ccRCC) without detectable genomic alterations remains unresolved. We investigated whether the long isoform of fatty acid‐binding protein 6 (FABP6L) contributes to this process. Analyses that distinguished FABP6 isoforms identified FABP6L as the principal tumour‐upregulated variant, whereas the short isoform, FABP6S, did not show a comparable increase. SHOX2 depletion preferentially reduced FABP6L expression. Biochemical experiments linked FABP6L to increased association between PTEN and the E3 ligase WWP2, enhanced PTEN polyubiquitination, and reduced PTEN protein stability. These changes were accompanied by increased AKT/mTOR signalling. Gain‐ and loss‐of‐function experiments supported a growth‐promoting role for FABP6L in cultured ccRCC cells and xenografts, while genetic rescue experiments indicated a major contribution of PTEN to the signalling and growth phenotypes. In preclinical models with reduced everolimus sensitivity, FABP6L depletion increased PTEN abundance and enhanced the response to mTOR inhibition. The findings support an isoform‐specific mechanism connecting FABP6L to PTEN turnover and ccRCC growth. They also provide a basis for investigating FABP6L‐directed approaches to improve everolimus response, although their clinical relevance requires further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Peking University Third Hospital, Beijing, China.
- Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Haoming Yin, Zijie Wang, Fan Shu, Ye Yan, Hui Liang, Shudong Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yin, H., Wang, Z., Ge, L., Liu, W., Shu, F., Yan, Y., Liang, H., & Zhang, S. (2026). The long isoform of FABP6 facilitates WWP2‐mediated PTEN ubiquitination to activate AKT/mTOR signalling and contributes to reduced everolimus sensitivity in clear cell renal cell carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70880
Vancouver
Yin H, Wang Z, Ge L, Liu W, Shu F, Yan Y, et al. The long isoform of FABP6 facilitates WWP2‐mediated PTEN ubiquitination to activate AKT/mTOR signalling and contributes to reduced everolimus sensitivity in clear cell renal cell carcinoma. Clinical and Translational Medicine. 2026. doi:10.1002/ctm2.70880
BibTeX
@article{Yin2026,
author = {Yin, Haoming and Wang, Zijie and Ge, Liyuan and Liu, Wei and Shu, Fan and Yan, Ye and Liang, Hui and Zhang, Shudong},
title = {The long isoform of FABP6 facilitates WWP2‐mediated PTEN ubiquitination to activate AKT/mTOR signalling and contributes to reduced everolimus sensitivity in clear cell renal cell carcinoma},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70880}
}
EUVIMED